News und Analysen
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity
Acrobat Genomics, NanoString, and Illumina Accelerator Collaborate with Stanford Medicine to Discover New Drug Targets for Gene Editing-Based Therapeutics
Acrobat Genomics, NanoString Technologies, Inc. (NASDAQ:NSTG), and the Illumina Accelerator announced today their collaboration with Stanford Medicine to discover new drug targets for gene
EQS-News: Eckert & Ziegler: PentixaPharm Receives BfArM-Clearance for its Therapeutic to conduct a Clinical Trial in Lymphoma
EQS-News: ckert & Ziegler: Annual General Meeting Approves Dividend of EUR 0.50 per Share. Reorganization of the Executive Board, Supervisory Board and Group Executive Committee.
Owkin Powers a New Era in Oncology Research with MOSAIC – An Unprecedented $50 Million Spatial Atlas of Cancer Cells
Owkin, Nanostring (NASDAQ:NSTG), and world-leading cancer research institutions University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum
EQS-News: M1 Kliniken AG publishes Q1 figures 2023: Strong growth and disproportionate increase in operating result
NanoString to Webcast Presentation from Jefferies Healthcare Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a
EQS-News: Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment
EQS-News: Eckert & Ziegler to Host First Radionuclide Theranostics Forum in Boston, MA
MD Medical Group Investments Plc: MD Medical Group announces intention to delist GDRs from the LSE
NanoString to Host Conference Call on Monday, May 22, 2023, to Provide Comments on Decision of the Regional Court of Munich
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will host a conference call on
NanoString nimmt Stellung zur Entscheidung des Landgerichts München
NanoString Technologies, Inc. (Nasdaq: NSTG), ein führender Anbieter von biowissenschaftlichen Werkzeugen für die Forschung und die translationale Forschung, reagierte heute auf die jüngste
NanoString Responds to Decision of the Regional Court of Munich
NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today responded to the Regional Court of Munich’s recent decision
Inogen to Present at 43rd Annual William Blair Growth Stock Conference
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in the William
EQS-News: Reorganization in the Executive Board of Eckert & Ziegler
EQS-News: Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate
EQS-News: Eckert & Ziegler with Strong Sales Growth in the First Quarter of 2023
Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the release of a new integrated
Owens & Minor to Present at the BofA Securities 2023 Health Care Conference on Tuesday, May 9, 2023
Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services, announced today that Ed
EQS-News: Eckert & Ziegler: Recognized Australian Endocrine & Hypertension Center Joins International Groups with a Clinical Trial of PentixaPharm’s Primary Aldosteronism Lead Candidate
Owens & Minor Reports First Quarter 2023 Financial Results
Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2023.
Key Highlights:
-
Consolidated revenue of $2.5 billion in the first quarter
-
Net
Inogen Announces First Quarter 2023 Financial Results
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31
EVO ICL Sponsors Jonas Brothers’ The Tour
EVO ICL, the vision correction procedure that works in harmony with your natural eye, provides sharp, clear vision day or night and does not cause contact lens induced dry eye or dry eye syndrome
EQS-News: MediClin AG: Encouraging development of Group sales in the first quarter of 2023
EQS-News: MediClin AG: Mercurius Health acquires Robert Janker Klinik in Bonn, Germany, previously owned by MEDICLIN